Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: Relationships with B cell depletion, circulating antibodies, and clinical relapse-Reference-Cited by-同舟云学术

Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: Relationships with B cell depletion, circulating antibodies, and clinical relapse

Published:2006 Issue:3 Volume:54 Page:723-732
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Cambridge Geraldine,Stohl William,Leandro Maria J.,Migone Thi-Sau,Hilbert David M.,Edwards Jonathan C. W.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference45 articles.

1. Prospects for B-cell-targeted therapy in autoimmune disease

2. Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

3. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

4. BLyS: Member of the Tumor Necrosis Factor Family and B Lymphocyte Stimulator

5. BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic role of anti‐nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases;Immunological Reviews;2024-09-09

2. Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study;Annals of the Rheumatic Diseases;2024-08-19

3. Update on the pathophysiology and treatment of primary Sjögren syndrome;Nature Reviews Rheumatology;2024-07-09

4. B‐1 lymphocytes in adipose tissue as innate modulators of inflammation linked to cardiometabolic disease;Immunological Reviews;2024-05-15

5. B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans;Science Translational Medicine;2024-03-06